Low dose radiotherapy in indolent lymphomas, enough is enough

Area of Science:

• Oncology
• Radiation Oncology
• Hematology

Background:

• Follicular lymphoma (FL) is an indolent non-Hodgkin lymphoma.
• FL serves as a model for radiation sensitivity in indolent lymphomas.

Purpose of the Study:

• To review the clinical presentation of follicular lymphoma.
• To summarize literature data on the efficacy of low-dose radiotherapy (RT) in various stages and relapse settings of FL.
• To explore the molecular mechanisms of RT response in FL.

Main Methods:

• Literature review of clinical studies on FL treated with RT.
• Analysis of data on first-line curative irradiation for stage I-II FL.
• Review of low-dose total body irradiation (TBI) and involved field radiotherapy (IF-RT) for advanced-stage and relapsed FL.
• In vivo imaging of apoptotic cell death.
• Gene expression profiling to identify molecular pathways.

Main Results:

• Low-dose RT, including TBI and IF-RT, demonstrates clinical efficacy in FL.
• Specific protocols like 2 x 2 Gy IF-RT show promise in relapsed FL.
• Apoptotic cell death is a key mechanism underlying RT response.
• Gene expression profiling suggests specific molecular pathways involved in low-dose RT sensitivity.

Conclusions:

• Follicular lymphoma is highly responsive to low-dose radiotherapy.
• Radiotherapy, particularly low-dose IF-RT, is a viable treatment option for various stages and relapse scenarios in FL.
• Understanding the molecular basis of RT sensitivity can further optimize treatment strategies.